CMV VIREMIA
Clinical trials for CMV VIREMIA explained in plain language.
Never miss a new study
Get alerted when new CMV VIREMIA trials appear
Sign up with your email to follow new studies for CMV VIREMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common virus help brain tumors grow? new trial tests Anti-Viral drug in breast cancer patients
Disease control Recruiting nowThis phase II trial is testing whether an anti-viral drug called valganciclovir (Valcyte) can help treat breast cancer that has spread to the brain. The study includes 28 adults with progressive brain metastases who also have evidence of a common virus called CMV. Participants ta…
Matched conditions: CMV VIREMIA
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Heart transplant patients may get safer virus protection
Disease control Recruiting nowThis study tests whether a newer drug, letermovir, is safer and more effective than the standard valganciclovir for preventing CMV infection in heart transplant recipients. About 150 moderate- to high-risk adults will be enrolled. The main focus is on reducing side effects like l…
Matched conditions: CMV VIREMIA
Phase: PHASE2, PHASE3 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC